The Patent Finder
US

Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders

US 8,236,773 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Nov 11, 2026 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Filed Aug 26, 2008 as application 11/884,411 · Granted Aug 7, 2012
Base term plus 635 days of patent term adjustment (USPTO delay)
Today
20 years from filing
Term ended Nov 11, 2026
2005 2026
Clock starts
Feb 14, 2005
Term ended
Nov 11, 2026
Granted
Aug 7, 2012
base term patent term adjustment after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
635
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 635 days past its 20-year base term on prosecution delay. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 14, 2005, when application 11/058,134, the earliest non-provisional in its chain, was filed (this one was filed Aug 26, 2008); a parent in its chain could not be resolved (the next row)Feb 14, 2025High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+635 days, USPTO patent term adjustment recordNov 11, 2026High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderNov 11, 2026Medium confidence

This family

US 7,803,931Term ended
Feb 2025
Feb 2025
US 7,538,211Term ended
Feb 2025
Feb 2025
US 7,579,456Term ended
no later than Feb 2025
no later than Feb 2025
US 8,236,773this patent
Nov 2026
Nov 2026
US 8,436,164Term ended
Feb 2025
Feb 2025
US 9,617,546Term ended
no later than Feb 2025
no later than Feb 2025
US 10,947,544Term ended
Feb 2025
Feb 2025
US 11,913,000Term ended
Apr 2025
Apr 2025
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 26, 2008
Reel 21443, frame 873
Benedict, Claude; Epstein, David; Wilson, Charles; McCauley, Dilara; Kurz, Jeffrey; McCauley, Thomas Greene; Rottman, James; Kurz, MarkusArchemix Corp.Assignment of Assignor's Interest
Jan 10, 2012
Reel 27510, frame 478
Archemix Corp.Archemix LLCMerger
Aug 5, 2022
Reel 61088, frame 48
Iveric Bio, Inc.Hercules Capital, Inc.Security Interest
Jul 17, 2023
Reel 64286, frame 472
Hercules Capital, Inc.Iveric Bio, Inc.; Iveric Bio Gene Therapy LLC; Orion Ophthalmology LLCRelease of Security Interest
Jul 17, 2023
reel/frame not recorded
Hercules Capital, Inc.Iveric Bio, Inc.Release of Security Interest
Jul 17, 2023
reel/frame not recorded
Hercules Capital, Inc.Iveric Bio Gene Therapy LLCRelease of Security Interest
Jul 17, 2023
reel/frame not recorded
Hercules Capital, Inc.Orion Ophthalmology LLCRelease of Security Interest
Sep 5, 2023
Reel 64797, frame 255
Archemix LLCIveric Bio., Inc.Assignment of Assignor's Interest
Jun 26, 2024
Reel 67851, frame 643
Iveric Bio, Inc.Astellas US LLCMerger

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited